FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093913683> ?p ?o ?g. }

• W2093913683 endingPage "895" @default.
• W2093913683 startingPage "888" @default.
• W2093913683 abstract "Oncolytic viruses with their capacity to specifically replicate in and kill tumor cells emerged as a novel class of cancer therapeutics. Rat oncolytic parvovirus (H-1PV) was used to treat different types of cancer in preclinical settings and was lately successfully combined with standard gemcitabine chemotherapy in treating pancreatic ductal adenocarcinoma (PDAC) in rats. Our previous work showed that the immune system and particularly the release of interferon-gamma (IFNγ) seem to mediate the anticancer effect of H-1PV in that model. Therefore, we reasoned that the therapeutic properties of H-1PV can be boosted with IFNγ for the treatment of late incurable stages of PDAC like peritoneal carcinomatosis. Rats bearing established orthotopic pancreatic carcinomas with peritoneal metastases were treated with a single intratumoral (i.t.) or intraperitoneal (i.p.) injection of 5x108 plaque forming units of H-1PV with or without concomitant IFNγ application. Intratumoral injection proved to be more effective than the intraperitoneal route in controlling the growth of both the primary pancreatic tumors and peritoneal carcinomatosis, accompanied by migration of virus from primary to metastatic deposits. Concomitant i.p. treatment of H-1PV with recIFNγ resulted in improved therapeutic effect yielding an extended animal survival, compared with i.p. treatment with H-1PV alone. IFNγ application enhanced the H-1PV-induced peritoneal macrophage and splenocyte responses against tumor cells while causing a significant reduction in the titers of H1-PV-neutralising antibodies in ascitic fluid. Thus, IFNγ co-application together with H-1PV might be considered as a novel therapeutic option to improve the survival of PDAC patients with peritoneal carcinomatosis." @default.
• W2093913683 created "2016-06-24" @default.
• W2093913683 creator A5020443258 @default.
• W2093913683 creator A5044899355 @default.
• W2093913683 creator A5047671567 @default.
• W2093913683 creator A5053605062 @default.
• W2093913683 creator A5059234407 @default.
• W2093913683 creator A5059888062 @default.
• W2093913683 creator A5070027273 @default.
• W2093913683 creator A5079050056 @default.
• W2093913683 creator A5079122246 @default.
• W2093913683 creator A5084723610 @default.
• W2093913683 creator A5087399868 @default.
• W2093913683 date "2011-11-15" @default.
• W2093913683 modified "2023-10-18" @default.
• W2093913683 title "Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer" @default.
• W2093913683 cites W1590342103 @default.
• W2093913683 cites W1991765451 @default.
• W2093913683 cites W2019101380 @default.
• W2093913683 cites W2033659551 @default.
• W2093913683 cites W2043991982 @default.
• W2093913683 cites W2049999948 @default.
• W2093913683 cites W2054373401 @default.
• W2093913683 cites W2078120018 @default.
• W2093913683 cites W2080083579 @default.
• W2093913683 cites W2101995865 @default.
• W2093913683 cites W2161520972 @default.
• W2093913683 cites W2164815073 @default.
• W2093913683 cites W2166834600 @default.
• W2093913683 cites W2167017590 @default.
• W2093913683 cites W2169577792 @default.
• W2093913683 doi "https://doi.org/10.4161/cbt.12.10.17678" @default.
• W2093913683 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3280904" @default.
• W2093913683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22024742" @default.
• W2093913683 hasPublicationYear "2011" @default.
• W2093913683 type Work @default.
• W2093913683 sameAs 2093913683 @default.
• W2093913683 citedByCount "34" @default.
• W2093913683 countsByYear W20939136832012 @default.
• W2093913683 countsByYear W20939136832013 @default.
• W2093913683 countsByYear W20939136832014 @default.
• W2093913683 countsByYear W20939136832015 @default.
• W2093913683 countsByYear W20939136832016 @default.
• W2093913683 countsByYear W20939136832017 @default.
• W2093913683 countsByYear W20939136832019 @default.
• W2093913683 countsByYear W20939136832020 @default.
• W2093913683 countsByYear W20939136832021 @default.
• W2093913683 countsByYear W20939136832022 @default.
• W2093913683 countsByYear W20939136832023 @default.
• W2093913683 crossrefType "journal-article" @default.
• W2093913683 hasAuthorship W2093913683A5020443258 @default.
• W2093913683 hasAuthorship W2093913683A5044899355 @default.
• W2093913683 hasAuthorship W2093913683A5047671567 @default.
• W2093913683 hasAuthorship W2093913683A5053605062 @default.
• W2093913683 hasAuthorship W2093913683A5059234407 @default.
• W2093913683 hasAuthorship W2093913683A5059888062 @default.
• W2093913683 hasAuthorship W2093913683A5070027273 @default.
• W2093913683 hasAuthorship W2093913683A5079050056 @default.
• W2093913683 hasAuthorship W2093913683A5079122246 @default.
• W2093913683 hasAuthorship W2093913683A5084723610 @default.
• W2093913683 hasAuthorship W2093913683A5087399868 @default.
• W2093913683 hasBestOaLocation W20939136831 @default.
• W2093913683 hasConcept C121608353 @default.
• W2093913683 hasConcept C126322002 @default.
• W2093913683 hasConcept C141071460 @default.
• W2093913683 hasConcept C142724271 @default.
• W2093913683 hasConcept C2778536324 @default.
• W2093913683 hasConcept C2780210213 @default.
• W2093913683 hasConcept C502942594 @default.
• W2093913683 hasConcept C71924100 @default.
• W2093913683 hasConcept C82210918 @default.
• W2093913683 hasConceptScore W2093913683C121608353 @default.
• W2093913683 hasConceptScore W2093913683C126322002 @default.
• W2093913683 hasConceptScore W2093913683C141071460 @default.
• W2093913683 hasConceptScore W2093913683C142724271 @default.
• W2093913683 hasConceptScore W2093913683C2778536324 @default.
• W2093913683 hasConceptScore W2093913683C2780210213 @default.
• W2093913683 hasConceptScore W2093913683C502942594 @default.
• W2093913683 hasConceptScore W2093913683C71924100 @default.
• W2093913683 hasConceptScore W2093913683C82210918 @default.
• W2093913683 hasIssue "10" @default.
• W2093913683 hasLocation W20939136831 @default.
• W2093913683 hasLocation W20939136832 @default.
• W2093913683 hasLocation W20939136833 @default.
• W2093913683 hasLocation W20939136834 @default.
• W2093913683 hasOpenAccess W2093913683 @default.
• W2093913683 hasPrimaryLocation W20939136831 @default.
• W2093913683 hasRelatedWork W1551219790 @default.
• W2093913683 hasRelatedWork W2075971121 @default.
• W2093913683 hasRelatedWork W2113309441 @default.
• W2093913683 hasRelatedWork W2206996832 @default.
• W2093913683 hasRelatedWork W2372806257 @default.
• W2093913683 hasRelatedWork W2388430340 @default.
• W2093913683 hasRelatedWork W2757241773 @default.
• W2093913683 hasRelatedWork W2757539927 @default.
• W2093913683 hasRelatedWork W4293088736 @default.
• W2093913683 hasRelatedWork W1507667107 @default.
• W2093913683 hasVolume "12" @default.

• next